These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 28192402

  • 1. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H, Peng Z, Tang H, Xie D, Jia Z, Zhong L, Zhao S, Ma Z, Gao Y, Zeng L, Luo R, Xie K.
    Oncogene; 2017 May 25; 36(21):2957-2968. PubMed ID: 28192402
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X, Wang F, Xue Y, Lin Z, Song W, Yang N, Li Q.
    Int J Mol Med; 2019 Mar 25; 43(3):1417-1429. PubMed ID: 30664155
    [Abstract] [Full Text] [Related]

  • 3. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
    Feng T, Dzieran J, Gu X, Marhenke S, Vogel A, Machida K, Weiss TS, Ruemmele P, Kollmar O, Hoffmann P, Grässer F, Allgayer H, Fabian J, Weng HL, Teufel A, Maass T, Meyer C, Lehmann U, Zhu C, Mertens PR, Gao CF, Dooley S, Meindl-Beinker NM.
    Clin Sci (Lond); 2015 Jun 25; 128(11):761-74. PubMed ID: 25602745
    [Abstract] [Full Text] [Related]

  • 4. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
    Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K.
    Gastroenterology; 2012 Sep 25; 143(3):799-810.e2. PubMed ID: 22677193
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG.
    Mol Cell Biol; 2007 Jun 25; 27(12):4488-99. PubMed ID: 17438144
    [Abstract] [Full Text] [Related]

  • 9. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ, Wang XH, Miao L, Liu Z, Zhang P, Zhang FM, Yang JB.
    World J Gastroenterol; 2006 Jan 28; 12(4):644-8. PubMed ID: 16489684
    [Abstract] [Full Text] [Related]

  • 10. Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.
    Sun H, Tang H, Xie D, Jia Z, Ma Z, Wei D, Mishra L, Gao Y, Zheng S, Xie K, Peng Z.
    Clin Cancer Res; 2016 Jan 15; 22(2):502-12. PubMed ID: 26338995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N, Jiao T, Huang Y, Liu W, Li Z, Ye X.
    J Virol; 2015 Mar 15; 89(5):2739-49. PubMed ID: 25540364
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug 15; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 16. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X, Wu J, Jiang Q, Cheng H, Han JJ, Chen YG.
    J Mol Cell Biol; 2018 Feb 01; 10(1):48-59. PubMed ID: 29036306
    [Abstract] [Full Text] [Related]

  • 17. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1.
    Boon RA, Fledderus JO, Volger OL, van Wanrooij EJ, Pardali E, Weesie F, Kuiper J, Pannekoek H, ten Dijke P, Horrevoets AJ.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):532-9. PubMed ID: 17194892
    [Abstract] [Full Text] [Related]

  • 18. Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer.
    Zhu M, Zhang N, He S.
    Pathol Res Pract; 2019 Aug 01; 215(8):152467. PubMed ID: 31146975
    [Abstract] [Full Text] [Related]

  • 19. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
    Tian C, Yao S, Liu L, Ding Y, Ye Q, Dong X, Gao Y, Yang N, Li Q.
    Int J Mol Med; 2017 Jan 01; 39(1):47-56. PubMed ID: 27909734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.